Balance Sheet Data

Karyopharm Therapeutics Inc. (KPTI)

$1.31

+0.07 (+5.65%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 328.20263.97273.46228.62277.971,189.151,986.173,317.395,540.849,254.56
Total Cash (%)
Account Receivables -7.8612.8822.5047.0947.1278.70131.45219.56366.71
Account Receivables (%)
Inventories -0.352.644.114.225.218.7014.5324.2640.52
Inventories (%)
Accounts Payable 4.330.984.451.602.7712.2420.4534.1657.0595.29
Accounts Payable (%)
Capital Expenditure -2.36-0.21-0.15-5.71-0.12-5.89-9.84-16.43-27.44-45.84
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.